JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
926
PUT
UnitedHealth
UNH
$333B
| $52.2M | 0.01% |
212,000
+120,900
| +133% | +$29.1M |
2014 Q3
19 quarters
|
|
927
McCormick & Company Non-Voting
MKC
$11.9B
| $52.1M | 0.01% |
669,068
+298,636
| +81% | +$23M |
2013 Q2
24 quarters
|
|
|
INXN
928
DELISTED
Interxion Holding N.V.
INXN
| $52.1M | 0.01% |
694,539
+140,653
| +25% | +$10M |
2014 Q2
20 quarters
|
|
929
Texas Roadhouse
TXRH
$10.3B
| $52.1M | 0.01% |
957,199
+74,010
| +8% | +$4.16M |
2013 Q2
24 quarters
|
|
930
Nektar Therapeutics
NKTR
$1.47B
| $52.1M | 0.01% |
100,118
-44,917
| -31% | -$22.5M |
2013 Q2
24 quarters
|
|
|
BDXA
931
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $52M | 0.01% |
839,706
-24,277
| -3% | -$1.44M |
2017 Q2
8 quarters
|
|
|
932
CALL
AT&T
T
$165B
| $51.8M | 0.01% |
2,080,401
-975,126
| -32% | -$23.4M |
2014 Q3
19 quarters
|
|
933
Tenet Healthcare
THC
$20.9B
| $51.7M | 0.01% |
2,547,080
-428,931
| -14% | -$9.89M |
2013 Q2
24 quarters
|
|
934
PUT
Comcast
CMCSA
$75.7B
| $51.7M | 0.01% |
1,230,000
+1,200,000
| +4,000% | +$50.6M |
2016 Q2
12 quarters
|
|
|
CY
935
DELISTED
Cypress Semiconductor
CY
| $51.6M | 0.01% |
2,324,651
+580,439
| +33% | +$10.5M |
2013 Q2
24 quarters
|
|
936
iShares MSCI USA Value Factor ETF
VLUE
$9.45B
| $51.5M | 0.01% |
640,919
-4,199,154
| -87% | -$336M |
2015 Q4
14 quarters
|
|
937
CALL
Bank of America
BAC
$376B
| $51.5M | 0.01% |
1,824,300
+83,300
| +5% | +$2.4M |
2014 Q3
19 quarters
|
|
938
Trustmark
TRMK
$2.64B
| $51.4M | 0.01% |
1,571,812
+28,432
| +2% | +$961K |
2013 Q2
24 quarters
|
|
939
PUT
Blackstone
BX
$82B
| $51.4M | 0.01% |
1,160,300
+465,300
| +67% | +$18.6M |
2016 Q2
12 quarters
|
|
940
Ovintiv
OVV
$16.6B
| $51.4M | 0.01% |
2,051,177
+1,399,872
| +215% | +$43.7M |
2013 Q2
24 quarters
|
|
|
TCF
941
DELISTED
TCF Financial Corporation
TCF
| $51.3M | 0.01% |
2,513,193
-48,563
| -2% | -$1.01M |
2013 Q2
24 quarters
|
|
942
Agilent Technologies
A
$47.3B
| $51.2M | 0.01% |
699,366
-82,845
| -11% | -$6.14M |
2013 Q2
24 quarters
|
|
|
MDRX
943
DELISTED
Veradigm Inc. Common Stock
MDRX
| $51.1M | 0.01% |
4,465,650
+3,057,330
| +217% | +$31.1M |
2013 Q2
24 quarters
|
|
944
Fortinet
FTNT
$134B
| $51.1M | 0.01% |
3,330,505
+644,145
| +24% | +$10.6M |
2013 Q2
24 quarters
|
|
945
PUT
Itaú Unibanco
ITUB
$111B
| $50.6M | 0.01% |
7,400,762
-563,475
| -7% | -$3.55M |
2017 Q4
6 quarters
|
|
946
PUT
Bristol-Myers Squibb
BMY
$122B
| $50.5M | 0.01% |
1,120,800
-838,500
| -43% | -$39.1M |
2014 Q2
20 quarters
|
|
947
PUT
Amgen
AMGN
$217B
| $50.4M | 0.01% |
274,100
-29,500
| -10% | -$5.28M |
2014 Q3
19 quarters
|
|
948
Cirrus Logic
CRUS
$6.04B
| $50.2M | 0.01% |
1,159,186
-85,266
| -7% | -$3.7M |
2013 Q2
24 quarters
|
|
949
PUT
Texas Instruments
TXN
$265B
| $50.1M | 0.01% |
432,700
+64,400
| +17% | +$7.2M |
2016 Q4
10 quarters
|
|
|
WWE
950
DELISTED
World Wrestling Entertainment
WWE
| $49.8M | 0.01% |
689,682
-268,497
| -28% | -$22M |
2016 Q4
10 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.